BOLT vs HAS · rev $7.7M vs P/E 25, rev $4.75B
Bolt Biotherapeutics (BOLT) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Hasbro Inc (HAS) is a leisure company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
BOLT currently screens at market cap $11.3M. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the BOLT and HAS stock pages for the full models.
Not investment advice.